• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-404
Device Problem Biocompatibility (2886)
Patient Problems Abscess (1690); Bacterial Infection (1735); Hypersensitivity/Allergic reaction (1907); Inflammation (1932); Rash (2033); Swelling/ Edema (4577)
Event Date 03/25/2024
Event Type  Injury  
Event Description
On (b)(6) 2024 a physician used a venaseal closure system during treatment of a soft tissue lesion in the patients left distal great saphenous vein (gsv).78cm of vein was treated.There were no abnormalities reported in relation to anatomy.Only one leg was treated.This was an initial reaction event.The blue introducer was used.There were no challenges or deviations related to location of catheter tip prior to initial delivery of adhesive.The catheter tip was 5cm caudal to sfj.There are no known co-morbidities.There are no known co-morbidities.75 days post procedure, patient appears to have a suspected hypersensitive reaction to venaseal.On 25-mar-2024 patient developed a sore on lower portion of the leg treated with venaseal.On 29-mar-2024 when the patient came in for a follow up he had developed a second sore just below the first sore.There was also swelling present in the treated leg as seen from ultrasound and ct imaging, with the ct imaging referencing abscesses and edema.The patient admitted to picking at the sore and puss came from the sore.The clinician swabbed the sore to have it cultured and it came back positive for staph.Patient was treated with prednisone 12 day taper 30mg day 1-4, 20mg day 5-8, 10mg day 9-12; augmentin q12h for 14 days, doxycycline hyclate twice daily fo r 14 days.Issue is still present.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19086465
MDR Text Key339884630
Report Number9612164-2024-01735
Device Sequence Number1
Product Code PJQ
UDI-Device Identifier00763000240776
UDI-Public00763000240776
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-404
Device Lot Number73037
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/04/2024
Initial Date FDA Received04/11/2024
Date Device Manufactured07/18/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient SexMale
Patient Weight86 KG
-
-